Opening announced of Australia's first clinic to provide fMRI-guided brain stimulation therapy for depression.

Using methodology developed by our team, stimulation will be targeted to the precise location of specific brain circuits mapped from a patient's brain scans.

Well done to Maria Di Biase on award of the MMS Strategic Grant for Outstanding Women 2021.

The grant will allow Maria to translate lab-based discoveries into clinical care for patients with schizophrenia, and develop her leadership capacity through individualised training.

We're Looking forward to OHBM 2021! Caio Seguin will lead a symposium on brain network communication.

Sina Mansour, Saampras Ganesan, Ye Tian and Mangor Pedersen will present their recent work in connectomics. And don't forget to check out our educational course on network neuroscience.

Ye Tian participated in Neurochat 2021, a three-day online workshop for neuroimaging researchers in China. Ye's presentation was viewed by hundreds of attendees and provided an overview of research that she completed during her PhD candidature.

Sina Mansour presented his research on high-resolution connectomics at the OHBM Australia Chapter Webinar. He has established new tools to to map connectomes at high-resolution using diffusion MRI.

Ye Tian presented an invited seminar on the Melbourne subcortex atlas as part of the first workshop on the subcortex.

Congratulations to Ye Tian who received numerous prizes and awards in the last few weeks for her PhD research published in Nature Neuroscience.

Ye Yian was awarded first prize in the 2020 Mendelsohn Student Award! The Mendelsohn recognizes excellence in doctoral neuroscience research.

Vanessa Cropley was awarded the DKCF, recognizing her outstanding research performance! Each of the Fellows has made contributions to MDHS through exceptional research and wider involvement, both in our local community and the world stage.

New research has created the most detailed subcortical atlas to date, mapping the most ancient part of our brain – the subcortex.

Andrew Zalesky was recognised in the annual highly-cited researchers list by Clarivate Analytics, ranking him in the top 1% of researchers in his field according to citations.

Andrew Zalesky was interviewed on ABC Evening Radio by David Astle about new research on mapping the human subcortex and applying this research to develop improved brain stimulation therapies for obsessive-compulsive disorder .

Research led by Robin Cash on a biomarker for TMS treatment outcome was voted best paper published in Human Brain Mapping over the course of 2019. Candidates for the Editor's Choice Award are nominated by the Associate Editors of Human Brain Mapping, and the final selection is made by the Editor-in-Chief together with the two Deputy Editors-in-Chief after weighing all the nominated papers.

Andrew Zalesky was voted one of Australia's most innovative engineers by Engineers Australia for developing new tools to analyze brain networks.

Caio Seguin received first-prize in the Mendelsohn award and shared his research project in neural communication and the clinical relevance of network communication models in understanding how neural signals are affected during disease.

Brain regions exchange information by sending and receiving signals through a network of nerve connections. This exchange is crucial to all aspects of the brain’s functioning, including how we experience the world, form and retrieve memories, and make decisions.

Hosted by the Systems Group, the Australian School on Connectomics showcased internationally recognised experts, in the field of connectomics, from Australia and abroad. Attracting 40 national and international attendees, sessions covered the fundamentals of connectomics and provided participants with the necessary tools for initiating their own analyses.

Caio Seguin developed a new network communication model to explain how brain networks can be navigated to achieve efficient information transfer.

Maria Di Biase reports evidence of an overactive immune system in some individuals with schizophrenia. Reducing microglia activation may ameliorate or even prevent the development of psychosis in at-risk individuals.